Report overview
Fungal Foot is a common skin infection of the feet caused by fungus. Signs and symptoms often include itching, scaling, cracking and redness. In rare cases the skin may blister. Athlete's foot fungus may infect any part of the foot, but most often grows between the toes.
This report contains market size and forecasts of Fungal Foot Drugs in global, including the following market information:
Global Fungal Foot Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Fungal Foot Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Fungal Foot Drugs companies in 2021 (%)
The global Fungal Foot Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cream Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Fungal Foot Drugs include Bayer, GSK, Johnson & Johnson, Novartis, Bausch Health, TEVA, Taro Pharmaceutical, WellSpring Pharma and Crown Laboratories and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Fungal Foot Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fungal Foot Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Fungal Foot Drugs Market Segment Percentages, by Type, 2021 (%)
Cream
Spray
Others
Global Fungal Foot Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Fungal Foot Drugs Market Segment Percentages, by Application, 2021 (%)
Offline Store
Online Store
Global Fungal Foot Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Fungal Foot Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fungal Foot Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Fungal Foot Drugs revenues share in global market, 2021 (%)
Key companies Fungal Foot Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Fungal Foot Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
GSK
Johnson & Johnson
Novartis
Bausch Health
TEVA
Taro Pharmaceutical
WellSpring Pharma
Crown Laboratories
Medimetriks Pharmaceuticals
